Fennec Pharmaceuticals Inc. (FENC) News
Follow Fennec Pharmaceuticals Inc. (FENC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
FENC - Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026
FENC - Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026
NEWS | Sep 17, 2026, 11:34 AM UTC
L
HC Wainwright maintains $16.00 Fennec Pharmaceuticals price target
HC Wainwright & Co. maintained its $16.00-per-share price target on Fennec Pharmaceuticals, per Benzinga ratings actions.
EQUITY | Sep 09, 2026, 11:28 AM UTC
L
FENC - Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026
FENC - Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026
EARNINGS | Aug 05, 2026, 11:01 AM UTC